Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
37.80
-0.10 (-0.26%)
Apr 2, 2025, 4:32 PM CET
-43.33%
Market Cap 695.67M
Revenue (ttm) 345.76M
Net Income (ttm) -6.10M
Shares Out 18.36M
EPS (ttm) n/a
PE Ratio n/a
Forward PE 29.96
Dividend n/a
Ex-Dividend Date n/a
Volume 21,094
Average Volume 16,251
Open 38.00
Previous Close 37.90
Day's Range 37.20 - 38.50
52-Week Range 37.20 - 73.00
Beta 0.08
RSI 23.57
Earnings Date Mar 28, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, analytical and solid state chemistry, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, auto... [Read more]

Sector Healthcare
Founded 2007
Employees 886
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.